Status: Recruiting
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-90Biological sex: AllType: InterventionalSponsor: Sam TyagiUpdated: Oct 20, 2025Locations: 1
Eligibility criteria
willing to give informed consent [+2]
allergy to ketamine, acetaminophen, or fentanyl [+4]